# Advisor Review - Advisor 3/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-27T11:10:22.002477
**Response ID:** resp_0ba7dca3481a181a00697871cf3bd08197bf1701530947dfc0
**Tokens:** 10132 in / 5838 out
**Response SHA256:** c2dffdebdddc7cda

---

Checked the draft only for **fatal** problems in (1) data–design alignment, (2) regression sanity, (3) completeness, and (4) internal consistency. I do **not** find any fatal errors that would make the empirical design impossible, the tables obviously broken, or the manuscript incomplete in the sense defined.

### 1) DATA–DESIGN ALIGNMENT (CRITICAL)
- **Treatment timing vs. data coverage:** Treated cohorts’ first-full-treated years run through **2022 (CT)**, and the data run through **2023** (with **2020 omitted**). This is aligned: **max(treatment year) ≤ max(data year)**.
- **Post-treatment observations exist for each treated cohort:**  
  NJ (2010) has 2010–2023; RI (2014) has 2014–2023; NY (2018) has 2018–2023; WA (2020) has 2021–2023 because 2020 is missing for all states; DC (2021) has 2021–2023; MA (2021) has 2021–2023; CT (2022) has 2022–2023. So no cohort is “treated but never observed post.”
- **Treatment definition consistency:** “First full treated year” is used consistently in Table 1, the treatment coding description, and the cohort labels used in the results.

### 2) REGRESSION SANITY (CRITICAL)
Reviewed Tables 3–4 for obvious red flags:
- Coefficients are in reasonable ranges for percentage-point outcomes (e.g., Table 3 col (2): **−0.187**, SE **0.140**).
- No implausibly huge SEs, no NaN/Inf/NA entries, no impossible confidence intervals.
- No missing N where required; N is reported in Tables 3–4.

### 3) COMPLETENESS (CRITICAL)
- No placeholders (TBD/TODO/XXX/NA) in the reported tables/figures shown.
- Regression tables include **standard errors** and **sample sizes**.
- Figures referenced (event study; cohort heterogeneity; adoption map; mean trends) are present in the provided excerpt.

### 4) INTERNAL CONSISTENCY (CRITICAL)
Spot-checked key numeric consistency:
- Table 3’s CS estimate (−0.187, SE 0.140) matches the **abstract** (≈ −0.19, SE 0.14).
- The reported 95% CI in Table 3 col (2) (≈ [−0.46, 0.09]) is arithmetically consistent with the coefficient and SE.
- Baseline control mean **7.41%** (Table 3 notes) matches Table 2 Panel B (“Control states 7.41”).

No contradictions were found that rise to the level of a fatal “claim-evidence mismatch” under your criteria.

ADVISOR VERDICT: PASS